Clinical Trials in Pittsburgh

Showing 16821-16840 of 18,076 trials

A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma

NCT00211276

The goal of this clinical research study is to find out if the study drug, ONTAK (denileukin diftitox), can shrink or slow the growth of B-cell non-Hodgkin's lymphoma (NHL) in patients whose disease has not responded to prior treatments, or has relapsed after an initial response to prior treatments. The safety of treatment with ONTAK will also be studied. The hypothesis is that patients with relapsed or refractory B-cell NHL and mild to moderate myelosuppression treated with ONTAK at a new dosing regimen will respond sufficiently to warrant further study.

Lymphoma, B-Cell

Eisai Inc.50 participantsStarted Mar 2005

Beverly Hills, California, United States • Fountain Valley, California, United States • Los Angeles, California, United States +9 more locations

COMPLETEDPhase 1< 1 mile

Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma

NCT00111696

To describe the tumor tissue saturation by MEDI-522 in patients with advanced malignant melanoma.

Malignant Melanoma

MedImmune LLC18 participantsStarted May 2005

Pittsburgh, Pennsylvania, United States

A Study of ONTAK in Patients With Relapsed or Refractory, B-Cell Non Hodgkin's Lymphoma

Study of the Tumor Saturation and Biological Activity of MEDI-522 (Abergrin) in Patients With Advanced Malignant Melanoma

Find Trials by Condition in Pittsburgh

A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome

Melatonin Osteoporosis Prevention Study

EEG Biomarkers for Predicting Response to Antidepressant Therapy

Phase II Study Alimta and Gemzar + Avastin as First Line Chemotherapy for Elderly Patients With Stage IIIB/IV NSCLC

Treatment Use Study With Sunitinib (SU011248) For Patients With Cytokine-Refractory Metastatic Renal Cell Carcinoma

SWOG-S9635 Fluorouracil Plus Ethynyluracil in Advanced Colorectal Cancer Not Responded to Fluorouracil

Pain Associated With Endometriosis

ETEC Logistics Trial (TREK)

APRiCOT-B: Study to Evaluate Apricoxib in Combination With Lapatinib and Capecitabine in the Treatment of HER2/Neu+ Breast Cancer (TP2001-202)

ABT-751 in Treating Young Patients With Refractory Solid Tumors

A Study of Silodosin 8 mg Daily for the Treatment of Nocturia in Men With Benign Prostatic Hyperplasia

GM-CT-01 Plus 5-Fluorouracil as Third- or Fourth-Line Therapy for Metastatic Colorectal Cancer

Study of Daclizumab in Patients With Chronic, Persistent Asthma

Pilot Study in Patients With Symptomatic Steroid-Naive Asthma

Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer

ADVANCE: Assessment for Defining Variability in Anesthesia Through Novel Clinical EEG

Visilizumab for Moderate to Severe Inflammatory, Nonstricturing, Nonpenetrating Crohn's Disease

A Study of Tadalafil in Men With Benign Prostatic Hyperplasia